Cargando…
Factor associated with SARS-CoV-2 vaccination serological efficacy in adolescents and adults with Down syndrome: Data from an international, collaborative initiative of the Trisomy 21 Research Society
Autores principales: | Valentini, D., Carfi, A., Di Paola, A., Yarci-Carrión, A., Villani, Alberto, Real de Asúa, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940466/ https://www.ncbi.nlm.nih.gov/pubmed/36813120 http://dx.doi.org/10.1016/j.jinf.2023.02.021 |
Ejemplares similares
-
Medical vulnerability of individuals with Down syndrome to severe COVID-19–data from the Trisomy 21 Research Society and the UK ISARIC4C survey
por: Hüls, Anke, et al.
Publicado: (2021) -
COVID-19 Vaccination of Individuals with Down Syndrome—Data from the Trisomy 21 Research Society Survey on Safety, Efficacy, and Factors Associated with the Decision to Be Vaccinated
por: Hüls, Anke, et al.
Publicado: (2022) -
On the origin of trisomy 21 Down syndrome
por: Hultén, Maj A, et al.
Publicado: (2008) -
Effect of a SARS-CoV-2 booster vaccine dose on the immune response of adults with Down syndrome
por: Yarci-Carrión, Ayla, et al.
Publicado: (2022) -
COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey
por: Emes, David, et al.
Publicado: (2021)